X

Create an account to continue reading.

Registered readers have access to our blogs and a limited number of magazine articles
For unlimited access to The Spectator, subscribe below

Registered readers have access to our blogs and a limited number of magazine articles

Sign in to continue

Already have an account?

What's my subscriber number?

Subscribe now from £1 a week

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
 
View subscription offers

Already a subscriber?

or

Subscribe now for unlimited access

ALL FROM JUST £1 A WEEK

View subscription offers

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Login

Don't have an account? Sign up
X

Subscription expired

Your subscription has expired. Please go to My Account to renew it or view subscription offers.

X

Forgot Password

Please check your email

If the email address you entered is associated with a web account on our system, you will receive an email from us with instructions for resetting your password.

If you don't receive this email, please check your junk mail folder.

X

It's time to subscribe.

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access – from just £1 a week

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
X

Sign up

What's my subscriber number? Already have an account?

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Your subscriber number is the 8 digit number printed above your name on the address sheet sent with your magazine each week.

Entering your subscriber number will enable full access to all magazine articles on the site.

If you cannot find your subscriber number then please contact us on customerhelp@subscriptions.co.uk or call 0330 333 0050.

You can create an account in the meantime and link your subscription at a later time. Simply visit the My Account page, enter your subscriber number in the relevant field and click 'submit changes'.

Please note: Previously subscribers used a 'WebID' to log into the website. Your subscriber number is not the same as the WebID. Please ensure you use the subscriber number when you link your subscription.

Coffee House

The dangers of cancer screening

2 April 2013

6:57 PM

2 April 2013

6:57 PM

Within five years, we could find out how genetically predisposed we are to developing certain types of cancer. Through DNA screening, the most susceptible of us will be prompted to adapt our lifestyles accordingly and ultimately reduce the risk of developing the disease. The breakthrough has been hailed as the ‘the biggest leap forward yet in understanding the genetic basis of cancer’. But at what cost?

The good news is clear enough. Researchers at the Institute of Cancer Research and Cambridge University have identified 74 ‘single nucleotide polymorphisms’ – small physical elements found on human DNA – that correlate with the probability of developing ovarian, breast and prostate cancer.  Of these, 16 are linked with the more aggressive forms of cancer.

[Alt-Text]


The idea is to introduce a nationwide saliva-based screening test to the NHS, which would cost the government £5 per person – a negligible amount compared to the hundreds of thousands currently spent on some patients suffering from progressive cancer. Given that one in eight women can contract breast cancer alone, the screening – if it works – may give millions of people the news that they are at risk from one of Britain’s biggest killers.

Those given a ‘high-risk’ profile would be monitored more closely to catch cancers before they proliferate. The advantage is obvious: there’s a far better chance of treating cancer if it’s caught in its earliest stages. But many would go through a lifetime of worry for nothing, since the 1 per cent of women and men who fall into the ‘high risk’ category of breast and prostate cancer will experience a 50/50 chance of developing the disease. Therefore, half of those who never develop the disease will spend their life under a cloud.

Also, there are depressingly few preventative measures available for the cancers in question. For those predisposed to ovarian cancer, the main options are limited to a double mastectomy or having your ovaries removed. The technology that allows people to be screened also opens up the possibility of people taking drastic preventative action for no reason, and those diagnosed as being low-risk may start to live unhealthy lives under the misconception that they are indestructible, making them more susceptible to other diseases.

The advances in DNA science raises many questions – but also risks. At present there seems to be too great a gap between knowing you are at high risk and being able to act upon it.

Subscribe to The Spectator today for a quality of argument not found in any other publication. Get more Spectator for less – just £12 for 12 issues.


Show comments
Close